Intrinsic Value of S&P & Nasdaq Contact Us

Upstream Bio, Inc. UPB NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
52/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$49.00
+396.5%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Upstream Bio, Inc. (UPB) has a negative trailing P/E of -3.7, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -27.07%.

Criteria proven by this page:

  • VALUE (100/100, Pass) — analyst target implies upside (+396.5%).
  • Trailing Earnings Yield -27.07% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.
  • Analyst consensus target $49.00 (+396.5% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 52/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
52/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
52/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
41/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — UPB

Valuation Multiples
P/E (TTM)-3.7
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio1.56
P/S Ratio186.27
EV/EBITDA-2.8
Per Share Data
EPS (TTM)$-2.64
Book Value / Share$6.26
Revenue / Share$0.05
FCF / Share$-2.46
Yields & Fair Value
Earnings Yield-27.07%
Dividend Yield0.00%
Analyst Target$49.00 (+396.5%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2022 -33.5 0.00 -7.53 659.33 -
2023 -38.9 -0.66 -6.49 335.76 -
2024 -13.4 -0.32 1.80 356.14 -
2025 -10.2 -0.13 4.30 512.30 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2022 $-0.66 $1.21M $-23.87M -1969.3%
2023 $-1.05 $2.38M $-20.54M -862.9%
2024 $0.00 $2.37M $-62.81M -2650%
2025 $-2.66 $2.85M $-143.44M -5026%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-2.94 $-3.51 – $-2.61 $1.41M $1.04M – $1.77M 7
2027 $-3.36 $-4.48 – $-2.31 $1.7M $1.45M – $1.95M 5
2028 $-4.35 $-5.32 – $-2.84 $5.67M $4.84M – $6.5M 5
2029 $-3.87 $-4.60 – $-3.13 $9.98M $8.51M – $11.45M 1
2030 $-3.34 $-3.97 – $-2.70 $106.72M $91.04M – $122.41M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message